India's IOL Chemicals gains on Europe regulator nod for bowel treatment drug

IOL Chemicals and Pharmaceuticals

20/01/2025 05:40

** IOL Chemicals  IOLC.NS  rises ~3% to 401.25 rupees
    ** Pharma and chemical products maker gets European drug
regulator's certificate of suitability for a drug used to treat
inflammatory bowel disease
    ** IOLC now will be able to export the drug, Mesalazine, to
European countries
    ** Global market size for Mesalazine drug has been estimated
to be worth ~$162 million in 2023 and projected to be $224
million by 2030 - pharma market research firm QY Research

 (Reporting by Bharath Rajeswaran in Bengaluru)
 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))